Suboptimal responses in chronic myeloid leukemia: implications and management strategies
about
Importance of early and deeper responses to long-term survival in CML patients: Implications of BCR-ABL testing in management of CML in Indian settingBCR-ABL V280G Mutation, Potential Role in Imatinib Resistance: First Case ReportIncreased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells.Analysis of 2013 European LeukaemiaNet (ELN) responses in chronic phase CML across four frontline TKI modalities and impact on clinical outcomes.Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.Second-generation TKIs: which and when?Kinase-inhibitor-insensitive cancer stem cells in chronic myeloid leukemia.Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily.Quality of life of chronic myeloid leukemia patients in Brazil: ability to work as a key factor.
P2860
Q27008389-0B95C7C1-5C57-4D5F-9657-C0884604F0D8Q33574738-BA7F9B68-D524-46E8-9CCB-B70227C643D9Q33815980-433A51C4-D031-453C-BAFE-3BCC964148EEQ36734508-B9500AD7-5E52-4DFA-BDA0-E152DD16B620Q36850854-B808DA54-AE92-4179-9FB7-43A010BAD0D0Q36852243-4EC56854-F242-4254-8891-2F834D4136F9Q38175466-B45D5A93-D26D-4326-839F-175778A0A16FQ38436037-7FE69B61-4F8F-4784-B61E-7531F01F95E7Q48082559-6C5CDF46-29DA-4302-9BF6-9E73184E4033
P2860
Suboptimal responses in chronic myeloid leukemia: implications and management strategies
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Suboptimal responses in chronic myeloid leukemia: implications and management strategies
@ast
Suboptimal responses in chronic myeloid leukemia: implications and management strategies
@en
type
label
Suboptimal responses in chronic myeloid leukemia: implications and management strategies
@ast
Suboptimal responses in chronic myeloid leukemia: implications and management strategies
@en
prefLabel
Suboptimal responses in chronic myeloid leukemia: implications and management strategies
@ast
Suboptimal responses in chronic myeloid leukemia: implications and management strategies
@en
P2860
P356
P1433
P1476
Suboptimal responses in chronic myeloid leukemia: implications and management strategies
@en
P2093
Giuseppe Saglio
Timothy P Hughes
P2860
P304
P356
10.1002/CNCR.26391
P407
P5008
P577
2011-10-28T00:00:00Z
2012-03-01T00:00:00Z